Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solution chemistry and analytical characterization of ormaplatin.

S E Northcott1, J G Marr, S L Secreast

  • 1Control Development Division, Upjohn Company, Kalamazoo, MI 49001.

Journal of Pharmaceutical and Biomedical Analysis
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

[Intestinal involvement in systemic lupus erythematosus: a clinicopathological analysis of three cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
Same author

[Quantitative analysis of policy texts on occupational health technical service institutions in China based on policy tools].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2026
Same author

[Clinical efficacy of multidisciplinary team collaboration in the treatment of deep sternal wound infection].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2025
Same author

Measurement of the Positive Muon Anomalous Magnetic Moment to 127 ppb.

Physical review letters·2025
Same author

[Clinical efficacy of composite transplantation of fascia lata-anterolateral thigh flap in repairing complex defects after radical tumor resection in maxillofacial region].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2025

Characterizing the purity of anticancer drug ormaplatin (platinum(IV)) is challenging due to solution instability and complex decomposition. New methods provide accurate purity determination and insight into its solution behavior.

Area of Science:

  • Pharmaceutical Chemistry
  • Analytical Chemistry
  • Medicinal Chemistry

Background:

  • Ormaplatin, a platinum(IV) anticancer drug, is in Phase 1 clinical trials.
  • Accurate characterization of ormaplatin purity is analytically challenging.
  • Instability in solution, impurities, and decomposition pathways complicate analysis.

Purpose of the Study:

  • To address the analytical challenges in characterizing ormaplatin purity.
  • To understand the decomposition pathways and solution equilibria of ormaplatin.
  • To develop reliable methods for determining bulk drug purity.

Main Methods:

  • Development of liquid chromatography and sample handling procedures.
  • Investigation of aqueous decomposition pathways (Pt(IV) and Pt(II) species).

Related Experiment Videos

  • Structural characterization of decomposition products using X-ray diffraction.

    • Main Results:

    • Identified two distinct aqueous decomposition pathways for ormaplatin.
    • Observed generation of soluble Pt(IV) and less soluble Pt(II) species.
    • Characterized a chloride-bridged mixed-valence Pt(II) material.

    Conclusions:

    • Developed robust methods for accurate ormaplatin purity determination.
    • Gained understanding of ormaplatin's complex solution stability and decomposition.
    • Characterization provides critical data for ongoing clinical trials.